Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for MEIS1
Z-value: 2.87
Motif logo
Transcription factors associated with MEIS1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MEIS1
|
ENSG00000143995.20 | MEIS1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MEIS1 | hg38_v1_chr2_+_66435116_66435135 | 0.15 | 4.2e-01 | Click! |
Activity profile of MEIS1 motif
Sorted Z-values of MEIS1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of MEIS1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 8.7 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
| 2.4 | 21.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.3 | 11.3 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 1.6 | 4.9 | GO:1904397 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 1.6 | 12.7 | GO:0061709 | reticulophagy(GO:0061709) |
| 1.5 | 13.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 1.3 | 4.0 | GO:1901877 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 1.3 | 17.4 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 1.3 | 12.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 1.2 | 3.5 | GO:0003168 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 1.1 | 3.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.8 | 5.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.8 | 7.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.8 | 2.5 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.8 | 4.9 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.8 | 2.5 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.8 | 2.4 | GO:1903937 | response to acrylamide(GO:1903937) |
| 0.8 | 3.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.8 | 7.0 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.8 | 4.6 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.8 | 2.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.8 | 2.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.8 | 2.3 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.8 | 3.0 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.7 | 2.2 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.7 | 16.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.7 | 2.9 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 0.7 | 2.9 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.7 | 4.9 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.7 | 3.4 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.7 | 9.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.6 | 0.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.6 | 2.6 | GO:0098942 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.6 | 5.0 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
| 0.6 | 6.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.6 | 0.6 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
| 0.6 | 4.9 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.6 | 1.8 | GO:1904956 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.6 | 1.8 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
| 0.6 | 2.9 | GO:0030070 | insulin processing(GO:0030070) |
| 0.6 | 4.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.6 | 2.8 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.6 | 6.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.6 | 6.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.5 | 4.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.5 | 2.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 | 3.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 | 1.5 | GO:0019417 | positive regulation of transcription via serum response element binding(GO:0010735) sulfur oxidation(GO:0019417) |
| 0.5 | 0.5 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.5 | 3.8 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.5 | 5.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.5 | 7.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.5 | 1.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.5 | 6.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.5 | 1.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.4 | 2.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.4 | 1.7 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.4 | 1.3 | GO:0016108 | tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 0.4 | 1.7 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.4 | 2.9 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 0.4 | 2.0 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.4 | 6.0 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.4 | 6.7 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.4 | 4.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.4 | 5.0 | GO:0030091 | protein repair(GO:0030091) |
| 0.4 | 3.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 2.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.4 | 3.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.4 | 1.1 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 7.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.4 | 4.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.4 | 1.1 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.4 | 24.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.4 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.4 | 1.1 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.4 | 4.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 | 1.7 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 0.3 | 17.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.3 | 6.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.3 | 3.8 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 | 0.7 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.3 | 4.1 | GO:0046959 | habituation(GO:0046959) negative regulation of growth hormone secretion(GO:0060125) |
| 0.3 | 1.3 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.3 | 2.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 2.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.3 | 1.6 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.3 | 7.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.3 | 1.3 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.3 | 7.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.3 | 2.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 | 1.5 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.3 | 3.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 0.3 | 1.8 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.3 | 1.5 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.3 | 3.2 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.3 | 5.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.3 | 2.0 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.3 | 2.0 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.3 | 4.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.3 | 3.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 2.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.3 | 2.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 | 1.9 | GO:0018032 | protein amidation(GO:0018032) |
| 0.3 | 6.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.3 | 4.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.3 | 1.6 | GO:0015853 | adenine transport(GO:0015853) |
| 0.3 | 1.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.3 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 0.2 | 2.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 5.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 1.0 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 1.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 0.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.2 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 | 1.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.2 | 2.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 | 2.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.2 | 8.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 6.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 7.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.2 | 1.3 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 | 0.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.2 | 1.2 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 0.2 | 2.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.2 | 3.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.2 | 1.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 1.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.2 | 1.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.2 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.2 | 1.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.2 | 1.9 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 1.9 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.2 | 2.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 1.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.2 | 9.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.2 | 1.1 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.2 | 4.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 | 1.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 1.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 1.0 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.2 | 3.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 0.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.2 | 0.3 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 | 3.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.6 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.2 | 1.8 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.2 | 0.9 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.2 | 1.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 | 7.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 1.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 | 0.7 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.1 | 0.4 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.1 | 1.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 1.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 0.8 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.1 | 0.6 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 | 2.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 2.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 2.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 4.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 3.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 1.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.1 | 2.8 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 0.4 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 | 0.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 1.0 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 1.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 | 1.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 1.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.1 | 2.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 3.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.1 | 0.8 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 | 0.5 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 | 2.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 2.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.1 | 3.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 1.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 2.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 5.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 1.4 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 1.5 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 2.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.1 | 3.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.1 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 0.1 | 0.9 | GO:1901558 | response to metformin(GO:1901558) |
| 0.1 | 0.5 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.1 | 0.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 | 0.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.5 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 | 5.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.1 | 2.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.1 | 4.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.9 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 1.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 1.6 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 0.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 1.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 2.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 | 2.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.7 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 | 0.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 | 0.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.1 | 0.6 | GO:0015692 | cadmium ion transport(GO:0015691) lead ion transport(GO:0015692) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.6 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
| 0.1 | 0.9 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 | 2.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 2.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) |
| 0.1 | 0.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.1 | 0.5 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.1 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 1.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.1 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.1 | 0.7 | GO:0061767 | positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
| 0.1 | 0.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 2.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 1.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.1 | 1.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.1 | 3.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 0.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 1.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
| 0.1 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 2.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.1 | 3.6 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 1.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 1.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.6 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.1 | 1.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 4.0 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.1 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 1.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 1.0 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.1 | 0.2 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.1 | 0.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 4.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.5 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.1 | 2.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 3.4 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 5.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 0.2 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 | 0.3 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.1 | 0.4 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 0.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 2.5 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 0.8 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.1 | 1.8 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 1.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 3.4 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.1 | 0.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 7.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.6 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 2.6 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.8 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 | 1.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 3.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 2.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 | 0.9 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 3.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 2.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 1.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 0.9 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.1 | 2.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 0.5 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.1 | 0.4 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 10.4 | GO:0003015 | heart process(GO:0003015) heart contraction(GO:0060047) |
| 0.1 | 0.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 2.5 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.1 | 3.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.1 | 2.3 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.1 | 2.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.1 | 0.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 7.9 | GO:0006941 | striated muscle contraction(GO:0006941) |
| 0.1 | 0.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.1 | 0.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 | 0.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 | 10.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 | 1.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 | 0.7 | GO:0097369 | sodium ion import(GO:0097369) |
| 0.0 | 0.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 1.2 | GO:0045056 | transcytosis(GO:0045056) |
| 0.0 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.0 | 1.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.9 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.0 | 0.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 1.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.0 | 0.4 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.0 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.0 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 1.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 1.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 1.8 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.4 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 | 1.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 1.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 0.6 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.0 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 2.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.0 | 0.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.0 | 1.0 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 3.6 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.0 | 7.6 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.0 | 1.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 1.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.0 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 | 0.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.0 | 1.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.0 | 1.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.0 | 0.4 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 0.1 | GO:0048058 | compound eye corneal lens development(GO:0048058) |
| 0.0 | 1.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 1.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 0.0 | 0.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.0 | 1.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.0 | 0.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 1.7 | GO:0048806 | genitalia development(GO:0048806) |
| 0.0 | 0.8 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.0 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 | 1.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 1.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 | 0.1 | GO:0039022 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric nephron tubule development(GO:0039020) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
| 0.0 | 3.6 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.0 | 0.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 0.9 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 | 7.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 1.4 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.0 | 0.7 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 18.3 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.0 | 0.9 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.8 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 | 0.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.9 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
| 0.0 | 0.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.0 | 1.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 | 0.9 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.9 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.0 | 0.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.0 | 0.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.0 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 | 0.1 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.1 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 | 1.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 8.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.0 | 0.7 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.0 | 0.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 0.9 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.0 | 1.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.7 | GO:0007632 | visual behavior(GO:0007632) |
| 0.0 | 0.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.0 | 2.1 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.0 | 0.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.0 | 0.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
| 0.0 | 0.3 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 0.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
| 0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.0 | 0.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.0 | 0.5 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.0 | 1.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.2 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 | 0.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 0.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.0 | 0.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 1.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.2 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of adherens junction organization(GO:1903391) |
| 0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 25.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.4 | 19.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.2 | 3.7 | GO:0030849 | autosome(GO:0030849) |
| 1.2 | 7.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.0 | 6.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.7 | 3.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.7 | 2.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.6 | 4.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.6 | 4.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.6 | 39.4 | GO:0031430 | M band(GO:0031430) |
| 0.5 | 2.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.5 | 4.9 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.5 | 4.9 | GO:0031673 | H zone(GO:0031673) |
| 0.5 | 2.6 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.5 | 2.9 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.5 | 2.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.5 | 3.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.5 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.4 | 2.0 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.4 | 11.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.4 | 4.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.4 | 4.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.4 | 1.1 | GO:1990844 | subsarcolemmal mitochondrion(GO:1990843) interfibrillar mitochondrion(GO:1990844) |
| 0.3 | 4.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.3 | 3.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 3.9 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.3 | 2.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.3 | 17.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.3 | 5.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.3 | 0.8 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.3 | 4.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.3 | 2.3 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.2 | 3.7 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 2.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 21.3 | GO:0030315 | T-tubule(GO:0030315) |
| 0.2 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 1.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.2 | 0.7 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 1.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 1.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 4.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.2 | 0.6 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.2 | 1.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 8.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.2 | 3.5 | GO:0031045 | dense core granule(GO:0031045) |
| 0.2 | 6.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 14.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.2 | 29.4 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 5.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 27.2 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.2 | 2.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.2 | 1.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 5.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.4 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 3.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 2.3 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 1.3 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 3.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 6.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 17.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 5.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 1.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 3.3 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 1.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 4.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.1 | 7.8 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 2.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
| 0.1 | 4.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.1 | 10.7 | GO:0030016 | myofibril(GO:0030016) |
| 0.1 | 0.3 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
| 0.1 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 4.7 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 6.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 6.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.1 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 41.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.1 | 1.9 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 3.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 24.6 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 8.0 | GO:0098793 | presynapse(GO:0098793) |
| 0.1 | 2.8 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.1 | 1.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 2.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 4.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 5.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 11.7 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 15.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 2.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 3.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.0 | 4.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 1.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.0 | 8.0 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 2.3 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 5.6 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 2.4 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 4.4 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 10.4 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 8.5 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.0 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.0 | 3.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.0 | 3.5 | GO:0060076 | excitatory synapse(GO:0060076) |
| 0.0 | 0.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.0 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.0 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.0 | 1.6 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 13.7 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.0 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 2.2 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 1.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.0 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 1.1 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.3 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 6.7 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.9 | GO:0044456 | synapse part(GO:0044456) |
| 0.0 | 1.0 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 8.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 9.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.6 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 1.8 | 7.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 1.7 | 6.7 | GO:0030379 | neurotensin receptor activity, non-G-protein coupled(GO:0030379) |
| 1.5 | 4.6 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.2 | 4.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.1 | 8.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 1.0 | 4.8 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.9 | 2.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.9 | 2.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.9 | 3.5 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.8 | 4.9 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.8 | 3.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.8 | 7.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.8 | 2.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.8 | 2.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.7 | 20.8 | GO:0031432 | titin binding(GO:0031432) |
| 0.7 | 3.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.7 | 4.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.7 | 15.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.7 | 2.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.7 | 6.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.6 | 19.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.6 | 1.8 | GO:0036326 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
| 0.6 | 10.7 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.6 | 5.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.5 | 3.3 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.5 | 3.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.5 | 1.6 | GO:0099530 | G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 0.5 | 2.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.5 | 5.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.5 | 2.6 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.5 | 4.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.5 | 2.5 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.5 | 1.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.4 | 14.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.4 | 2.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.4 | 4.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.4 | 4.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.4 | 4.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.4 | 1.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.4 | 2.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.4 | 3.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 7.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.7 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.3 | 1.0 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.3 | 3.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.3 | 2.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 3.9 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.3 | 1.0 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.3 | 5.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.3 | 4.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.3 | 0.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.3 | 35.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 1.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.3 | 3.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.3 | 1.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.3 | 4.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.3 | 3.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.3 | 2.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.3 | 2.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.3 | 2.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.3 | 1.9 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.3 | 1.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 2.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.3 | 2.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 1.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.3 | 9.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.3 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.2 | 7.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 1.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 2.4 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 19.2 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 3.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 4.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.2 | 1.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 2.5 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.2 | 1.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 5.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 4.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 8.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.2 | 1.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 22.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 4.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 0.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 1.3 | GO:0052843 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 6.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 1.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.2 | 1.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.2 | 5.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 6.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.2 | 9.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 1.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 2.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.2 | 1.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 1.0 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.2 | 0.9 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 1.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 6.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 4.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 1.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.2 | 0.9 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.2 | 27.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.2 | 1.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 0.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 7.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 1.3 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.2 | 2.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.2 | 0.5 | GO:0070975 | FHA domain binding(GO:0070975) |
| 0.2 | 2.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 4.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 2.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 5.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 1.9 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.1 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.1 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 0.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.1 | 2.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 3.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 4.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 3.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 2.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.1 | 0.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.1 | 3.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 1.0 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.1 | 0.4 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 3.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 0.4 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 3.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 1.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 7.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.9 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 2.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 2.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 1.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 0.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 1.1 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.1 | 5.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.5 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.1 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 27.4 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 2.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 1.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 1.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 3.2 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 1.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 1.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.4 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.1 | 2.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 0.6 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 0.9 | GO:0042835 | BRE binding(GO:0042835) |
| 0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 3.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.1 | 2.5 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 1.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.1 | 1.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 3.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 6.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 1.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 17.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 0.2 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 2.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 3.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) ion gated channel activity(GO:0022839) |
| 0.1 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 0.2 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.1 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.1 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.1 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.5 | GO:0044020 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.1 | 1.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.8 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 1.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 14.9 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 0.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 2.4 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 3.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 0.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 8.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 4.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.1 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 2.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 5.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 1.5 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 18.1 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 1.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.0 | 0.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 1.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 5.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.0 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 1.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.0 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 2.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 3.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.0 | 0.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.0 | 1.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 3.2 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 1.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 2.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 1.4 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.0 | 3.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 2.5 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
| 0.0 | 1.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.0 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.0 | 0.4 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 2.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 1.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 0.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.0 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.0 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.0 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 2.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.0 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.0 | 0.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 0.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.0 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 3.0 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
| 0.0 | 8.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.7 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.1 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.0 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.1 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.0 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 2.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 8.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.0 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.0 | 0.8 | GO:0003774 | motor activity(GO:0003774) |
| 0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.2 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 13.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 4.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 7.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 5.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 0.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 4.2 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 40.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 10.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 9.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 3.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 3.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 1.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 7.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 7.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 3.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 10.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 0.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 2.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 5.3 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 9.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 7.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 5.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 1.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 6.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.2 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.0 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 1.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.0 | 1.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 3.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 2.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 2.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 2.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 1.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.5 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 1.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 14.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 8.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 3.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 10.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 9.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 11.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 13.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 11.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 4.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 4.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 2.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 15.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.1 | 5.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.1 | 4.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 9.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 4.3 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 2.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 6.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.1 | 2.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 3.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 3.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 5.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 2.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 6.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 0.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 3.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 7.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 1.1 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 2.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 4.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 1.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.1 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.1 | 1.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.1 | 2.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 1.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 4.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 1.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 3.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 1.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 1.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 11.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 5.3 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 1.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 2.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.0 | 2.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 1.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 2.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.0 | 3.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 1.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 1.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 1.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.0 | 4.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 1.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 1.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 1.9 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 1.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 5.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 5.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 1.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |